Biallelic variants in PIKFYVE cause a hypomyelinating leukodystrophy with endolysosomal dysfunction

Clicks: 8
ID: 332336
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #428 of 433 articles by views in Brain research

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 433 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract The PIKfyve-FIG4-VAC14 lipid kinase complex generates phosphoinositide PI(3,5)P2. Pathogenic variants in VAC14 and FIG4 cause neurodevelopmental disorders and PIKFYVE has been linked to autosomal dominant fleck corneal dystrophy. We searched for the underlyging, genetic cause of a neurodevelopmental disorder in five affected individuals from three families using exome- or genome sequencing. Cranial MRI images and clinical phenotypes were analyzed. Size, number and acidity of cellular vacuoles were investigated in patient-derived fibroblasts from family 1 using LysoSensor acidophilic probes. Levels of PI(3,5)P2 were quantified in patient-derived fibroblasts from family 1 using high-performance liquid chromatography-tandem mass spectrometry. Pikfyve-mutant zebrafish larvae were injected with wildtype-mRNA or mutant mRNA harboring the PIKFYVE missense variant identified in family 3. Pikfyve-mutant zebrafish larvae were treated with metformin, bafilomycin A1, or rapamycin. We identified biallelic PIKFYVE variants in five affected individuals with hypomyelinating leukodystrophy, brain hyperintensities of inferior olives, thalami, long tracts, and optic nerves. Clinically, they presented with intellectual disability, spasticity, muscular weakness, and nystagmus. Additional features included feeding difficulties, auditory dysfunction, insulin resistance, microcephaly, peripheral neuropathy, and mild creatine kinase elevations. We detected four distinct PIKFYVE variants: three loss-of-function variants (family 1 & 2), and one p.Arg1156Pro missense variant (family 3). The pathogenicity of the p.Arg1156Pro variant was confirmed by phenotypic rescue of pikfyve-mutant zebrafish larvae injected with wildtype-mRNA but not with p.Arg1156Pro mRNA. Consistent with the role of PIKfyve in maintaining endolysosomal homeostasis, patient-derived fibroblasts of family 1 accumulated enlarged, hyperacidic vacuoles and showed a reduced PI(3,5)P2 production upon hyperosmotic stimulation. Exposing pikfyve-mutant zebrafisch larvae to the mTORC1 inhibitor and TRPML1 activator rapamycin attenuated cellular vacuolization, highlighting potential therapeutic approaches. Our findings establish PIKFYVE deficiency as a novel cause of hypomyelinating leukodystrophy and endolysosomal dysfunction.
Reference Key
openalex_W7221769116 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Luisa Averdunk, Martin Groß, Anna B. Hamacher, Sandra C. Donkervoort, Diran Agaid Herebian, Shekeeb S. Mohammad, Alexej Knaus, Annette Seibt, Joerg Schaper, Heinrich Sticht, Samantha J. Bryen, Ann Kathrin Bergmann, Miriam Langener, Lenika De Simone, A Markshausen, Guy Lenk, Sujal Ghosh, Sarah A. Sandaradura, Tanja Guthoff, Richard Jacob Leventer, Rotem Orbach, Rocío Rius, Nikola Morton, Kimberly Gilmour, Ertan Mayatepek, Peter Michael Krawitz, Carsten G. Bönnemann, Juliane Bremer, Felix Distelmaier
Journal Brain research
Year 2026
DOI
10.1093/brain/awag355
URL
https://doi.org/10.1093/brain/awag355
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.